Australia Mice Model Market (2025-2030)
The Australia Mice Model Market was valued at $24.1 Million in 2025 and projected to reach to $38 Million by 2030, representing a compound annual growth rate of 9.5%. Australia's mice model market is poised for sustained expansion through 2030, driven by increased government funding for biomedical research and the establishment of world-class research facilities across major universities and medical institutions.
Australia Mice Model Market Trends and Insights
- This 9.5% compound annual growth rate reflects Australia's strengthening position in biomedical research and pharmaceutical development.
- Australia's investment in life sciences infrastructure and research institutions is driving demand for high-quality mice models across academic and commercial laboratories. The Australian mice model market benefits from the country's advanced healthcare ecosystem and increasing collaboration between universities and pharmaceutical companies.
- Australia's regulatory environment and research funding mechanisms support the adoption of sophisticated animal models for drug discovery and disease research.
- By 2030, Australia is expected to solidify its role as a key hub for preclinical research in the Asia Pacific region, with mice models remaining essential to innovation pipelines. Australia's market growth is underpinned by rising R&D expenditure, expansion of contract research organizations, and growing demand for genetically modified and specialized mouse strains.
- The country's commitment to biomedical excellence positions it favorably within the broader Asia Pacific mice model landscape..
Key Market Statistics
- CAGR (2025-2030) 9.5% CAGR
- Market Size, 2025 ~USD 24.1 Million
- Forecast, 2030 ~USD 38 Million
- Country Australia
Australia Mice Model Market Overview
Market Valuation Growth :
Australia's mice model market is valued at $24.1 million in 2025, with projections reaching $38.0 million by 2030, representing a strong 9.5% CAGR driven by increased biomedical research investments.
Research Infrastructure Expansion :
Australia's leading research institutions and government funding initiatives are strengthening the demand for high-quality laboratory mice, positioning the country as a key hub for preclinical research in the Asia-Pacific region.
Pharmaceutical Development Hub :
Australian pharmaceutical companies and contract research organizations are increasingly adopting advanced mice models for drug development and safety testing, accelerating market growth in the domestic sector.
Competitive CAGR Performance :
At 9.5% CAGR, Australia's mice model market growth slightly outpaces global trends, reflecting the country's commitment to life sciences innovation and regulatory compliance in preclinical research.
Australia Mice Model Market Dynamics
- The country's strong regulatory framework and emphasis on ethical research practices are attracting international pharmaceutical companies to conduct preclinical studies locally.
- Additionally, collaborations between academic institutions and industry players are fostering innovation in transgenic and disease model development, further propelling market demand. The forecast growth to $38.0 million by 2030 reflects Australia's strategic positioning within the global life sciences ecosystem.
- Emerging focus areas including personalized medicine, immunotherapy research, and genetic disease modeling are creating new opportunities for specialized mice model suppliers.
- Government initiatives supporting local biotech development and the rising number of clinical trials requiring preclinical validation will continue to sustain market momentum throughout the forecast period..
Related Ecosystem
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- Australia's mice model market is valued at $24.1 million in 2025 and is forecast to reach $38.0 million by 2030, representing a 9.5% CAGR.
- Australia's advanced research infrastructure and university-industry partnerships are primary drivers of mice model demand across preclinical research.
- Genetically modified and specialized mouse strains are increasingly adopted in Australia for drug discovery and disease modeling applications.
- Australia's regulatory framework and biomedical investment position the country as a growing preclinical research hub within Asia Pacific.
Mice Model Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | SERVICES (Model Type & Service) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 10% from 2025 to 2030 |
| Largest Segment | MODEL TYPE (Model Type & Service) |
| Market Size Base Year (Billions) | ~USD 1.7 (2025) |
| Revenue Forecast (Billions) | ~USD 2.74 (2030) |
| Segments Covered | Model Type & Service, Type, Technology, Application, Therapeutic Area |
Australia Mice Model Market Report Segmentation
5 segment dimensions are covered across the global market.
By Model Type & Service
- Model Type
- Services
By Type
- Breeding Services
- Cryopreservation Services
- Genetically Engineered Mice
- Hybrid/Congenic Mice
- Inbred Mice
- Other Services
- Outbred Mice
- Quarantine Services
- Rederivation Services
By Technology
- Crispr/Cas9
- Embryonic Stem Cell Injections
- Microinjections
- Nuclear Transfer Technique
- Other Technologies
By Application
- Drug Discovery & Development
- Personalized Medicine
- Research Applications
By Therapeutic Area
- Cardiovascular Diseases
- Immunology
- Metabolic Diseases
- Neurology
- Oncology
- Other Therapeutic Areas
Target Audience
- Pharmaceutical Companies : Australian and international pharma firms conducting preclinical research need detailed market insights to source quality mice models, plan clinical trial timelines, and optimize R&D budgets for Australian operations.
- Contract Research Organizations (CROs) : CROs operating in Australia require market data to benchmark service offerings, identify supplier partnerships, and forecast demand for preclinical testing services from domestic and regional pharmaceutical clients.
- Research Institutions & Universities : Australian universities and medical research centers need market intelligence to justify procurement budgets, evaluate supplier options, and align research capabilities with emerging biomedical research trends.
- Mice Model Suppliers & Breeders : Domestic and international suppliers require Australia-specific market data to assess growth opportunities, understand competitive positioning, and develop targeted strategies for expanding market share in the region.
- Government & Policy Bodies : Australian government agencies and research funding bodies need market insights to inform life sciences policy, allocate research grants effectively, and support the development of Australia's biomedical research infrastructure.
Key Companies in the Australia Mice Model Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| HORIZON DISCOVERY GROUP PLC | United Kingdom | Private Company | Screening,Research Reagents,Diagnostics, |
| LABORATORY CORPORATION OF AMERICA HOLDINGS | United States | Public Company | Routine and wellness diagnostics (chemistry, hematology, urinalysis, wellness programs),Specialty and esoteric testing (gene-based, oncology, infectious disease, women’s health, pharmacogenetics),Biopharma Laboratory Services (clinical trial, central lab, medical device and diagnostic R&D), |
| CHARLES RIVER LABORATORIES | United States | Public Company | Discovery and Safety Assessment,Research Models and Services,Manufacturing Solutions, |
| THE JACKSON LABORATORY | United States | Foundation/Charitable Institution | Mouse breeding and colony management services,Cryopreservation, recovery, and genetic resource management,Phenotyping, efficacy testing, and study-ready induced models, |
| INOTIV | United States | Public Company | Research Models and Services (RMS),Discovery and Safety Assessment (DSA) Services,BASi Scientific Instruments and Software, |
| JSR CORPORATION | Japan | Private Company | Digital Solutions (lithography, photoresists, packaging, CMP, display materials),Plastics (synthetic resins: ABS, AES, AS, ASA),Life Sciences (diagnostic reagents, bioprocess materials, drug discovery support), |
| BIOCYTOGEN | China | Public Company | Gene-Editing Services,Pharmacological Efficacy & Toxicology Services,Model Animals (Breeding & Sales), |
| SHANGHAI MODEL ORGANISMS CENTER, INC. | China | Public Company | Standard and disease mouse models (including toolbox and disease-specific strains),Customized genetically engineered models (KO, KI, humanized, transgenic),Preclinical services (non-GLP tox, PK, pharmacology/PD, phenotype analysis), |
| TRANS GENIC INC. | Japan | Public Company | Drug Discovery Support (non-clinical, bioequivalence, safety tests),Transgenic Models & Reagents (GM mice, antibodies, proteins, cells),Glycan Synthesis & Sugar Chain Analysis, |
| HARBOUR BIOMED | China | Public Company | Harbour Mice platform licensing and collaborations,Immunology clinical assets (e.g., batoclimab, HBM7020, HBM9378),Oncology clinical assets (e.g., porustobart, solid tumor portfolio), |
| GENOWAY | France | Public Company | Custom KO/KI mouse models,Custom KO/KI rat models,Humanized and immunodeficient rodent models (catalog and custom), |
| GEMPHARMATECH | China | Public Company | Standard GEMM catalog (knockout, conditional, knock-in, point-mutation, transgenic),Custom model generation and tool mice,Preclinical testing services, |
| VIVO BIO TECH LTD. | India | Public Company | In vivo and in vitro toxicity, PK/TK, and pharmacology services,SPF lab animals, rodent breeding, custom models, and lab diets,Genotoxicity screening and analytical services, |
HORIZON DISCOVERY GROUP PLC
Horizon Discovery Group PLC is a United Kingdom-based private company founded in 2005 with 428 employees. The company operates in the life sciences sector, providing specialized research and development services.
LABORATORY CORPORATION OF AMERICA HOLDINGS
Laboratory Corporation of America Holdings is a major United States public company founded in 1995 with 66,385 employees. It is a leading provider of clinical laboratory services and drug development support.
CHARLES RIVER LABORATORIES
Charles River Laboratories is a United States public company founded in 1947 with 19,000 employees. The company provides preclinical and clinical laboratory services, research models, and safety assessment services.
THE JACKSON LABORATORY
The Jackson Laboratory is a United States foundation and charitable institution founded in 1929 with 2,100 employees. It is a premier research institution specializing in mammalian genetics and genomics.
INOTIV
Inotiv is a United States public company founded in 1974 with 1,996 employees. The company provides research models, services, and products for the pharmaceutical and biotechnology industries.
JSR CORPORATION
JSR Corporation is a Japan-based private company founded in 1948 with 7,997 employees. The company operates in advanced materials and life sciences sectors.
BIOCYTOGEN
Biocytogen is a China-based public company founded in 2008 with 1,443 employees. The company specializes in the development of genetically engineered animal models for research and drug development.
SHANGHAI MODEL ORGANISMS CENTER, INC.
Shanghai Model Organisms Center, Inc. is a China-based public company founded in 2000 with 848 employees. The company provides model organism services and products for biomedical research.
TRANS GENIC INC.
Trans Genic Inc. is a Japan-based public company founded in 1998 with 227 employees. The company develops and provides transgenic animal models for research applications.
HARBOUR BIOMED
Harbour Biomed is a China-based public company founded in 2016 with 272 employees. The company focuses on antibody and immunotherapy research and development.
GENOWAY
Genoway is a France-based public company founded in 1999 with 157 employees. The company specializes in the generation of genetically modified animal models for research.
GEMPHARMATECH
GemPharmatech is a China-based public company founded in 2017 with 1,590 employees. The company provides laboratory animal models and related research services.
VIVO BIO TECH LTD.
Vivo Bio Tech Ltd. is an India-based public company founded in 1987 with 174 employees. The company provides contract research services and laboratory animal models for pharmaceutical and biotechnology research.
Reasons to Buy this Report
- Market Size & Growth Validation : Obtain precise valuation data for Australia's mice model market ($24.1M in 2025) with verified 9.5% CAGR projections through 2030, enabling accurate business planning and investment decisions specific to the Australian market.
- Competitive Landscape Intelligence : Understand Australia's unique market dynamics, key suppliers, research institution partnerships, and regulatory environment to identify competitive advantages and market entry strategies tailored to the Australian biomedical sector.
- Investment & Expansion Planning : Leverage detailed Australia-specific forecasts to evaluate expansion opportunities, facility investments, and partnership development with Australian research institutions and pharmaceutical companies through 2030.
- Regulatory & Compliance Insights : Access Australia-specific regulatory requirements, ethical research standards, and compliance frameworks governing mice model production and distribution, ensuring market-compliant operations and supplier relationships.
- Demand Driver Analysis : Identify key growth catalysts in Australia including government funding trends, emerging research focus areas, and institutional demand patterns to optimize product offerings and marketing strategies for the Australian market.
Frequently asked questions
What is the current size of Australia's mice model market?
Australia's mice model market is valued at $24.1 million in 2025 and is expected to grow to $38.0 million by 2030.
What is the projected growth rate for Australia's mice model market?
Australia's mice model market is projected to grow at a compound annual growth rate (CAGR) of 9.5% from 2025 to 2030.
What factors are driving growth in Australia's mice model market?
Key drivers include increased R&D investment, expansion of contract research organizations, growing demand for genetically modified mouse strains, and strengthened university-industry collaborations in Australia.
Which sectors in Australia are the primary consumers of mice models?
Primary consumers in Australia include pharmaceutical companies, biotechnology firms, academic research institutions, and contract research organizations engaged in drug discovery and preclinical testing.
How does Australia's mice model market compare to the broader Asia Pacific region?
Australia represents a significant and growing segment of the Asia Pacific mice model market, driven by its advanced research infrastructure, regulatory environment, and biomedical innovation ecosystem.
RESEARCH METHODOLOGY
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global mice model market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
Secondary research was used primarily to identify & collect information for the extensive, technical, market-oriented, and commercial study. The secondary sources used for this study include the International Mouse Phenotyping Consortium (IMPC), Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC), European Molecular Biology Laboratory−European Bioinformatics Institute (EMBL-EBI), Swiss Laboratory Animal Science Association (SGV), Medical Research Council (MRC), Asian Mouse Mutagenesis Resource Association (AMMRA), Department of Biotechnology (DBT) (India), World Health Organization (WHO), United States Food and Drug Administration (US FDA), Annual Reports, SEC Filings, Investor Presentations, Research Journals, Press Releases, and financial statements. These sources also obtained key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate & validate the total size of the mice model market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Data Triangulation
The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
An animal model is a valuable resource in biomedical research, chosen for its ability to replicate certain aspects of biological processes or diseases observed in humans. A mouse model is a genetically engineered or naturally occurring mouse strain used in biomedical research to mimic human diseases or conditions. These models are valuable for their biological similarity to humans, ability to be genetically manipulated, and cost-effectiveness, enabling researchers to study disease mechanisms and test novel drug therapies efficiently. Mice share over 95% of human DNA and are biologically similar to humans, thereby being susceptible to similar diseases due to the genetic build-up.
Stakeholders
- Manufacturers & Distributors of Mice Models
- CROs & CDMOs
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Market Research & Consulting Firms
- Researchers & Scientists
- Regulatory Authorities & Institutes
Report Objectives
- To define, describe, and forecast the global mice model market based on model type & service, technology, therapeutic area, application, product end user, service end user, and region
- To provide detailed information regarding the leading factors driving the growth of the market (such as drivers, restraints, challenges, and opportunities)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall mice models market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- Track & analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the mice models market.
- To analyze and provide funding & investment activities, brand/product comparative analysis, and vendor valuation & financial metrics of the mice model market.
Get the Full Mice Model Market Report
Full forecast, segment splits, and company analysis for all Mice Model Market.
- US Mice Model Market
- Canada Mice Model Market
- Germany Mice Model Market
- UK Mice Model Market
- France Mice Model Market
- Italy Mice Model Market
- Spain Mice Model Market
- China Mice Model Market
- Japan Mice Model Market
- India Mice Model Market
- South Korea Mice Model Market
- Brazil Mice Model Market
- Mexico Mice Model Market
- United Arab Emirates Mice Model Market
- Rest Of Europe Mice Model Market
- Rest Of The Asia Pacific Mice Model Market
- Rest Of Asia Pacific Mice Model Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report